Conditions: Stroke; Chronic Stroke Patients; Arm Weakness as a Consequence of Stroke
Interventions: Device: kTMP sham stimulation 9 weeks + active stimulation 9 weeks; Device: kTMP 18 weeks
Sponsors: University of California, San Francisco; National Institute of Neurological Disorders and Stroke (NINDS)
Not yet **RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
